Trials / Completed

CompletedNCT02309671

A Dose-response Trial Using FE 999049 in Japanese Women Undergoing in Vitro Fertilisation (IVF) / Intracytoplasmic Sperm Injection (ICSI) Treatment

A Randomised, Controlled, Assessor-blind, Parallel Groups, Multicentre Trial Assessing the Dose-response Relationship of FE 999049 in Controlled Ovarian Stimulation in Japanese Women Undergoing an Assisted Reproductive Technology Programme

Status: Completed
Phase: Phase 2
Study type: Interventional
Enrollment: 159 (actual)

Sponsor: Ferring Pharmaceuticals · Industry
Sex: Female
Age: 20 Years – 39 Years
Healthy volunteers: Not accepted

Summary

This trial investigates the effects of several doses of FE 999049 in Japanese women undergoing IVF/ICSI treatment.

Conditions

Infertility

Interventions

Type	Name	Description
DRUG	FE 999049
DRUG	follitropin beta

Timeline

Start date: 2014-12-01
Primary completion: 2015-11-01
Completion: 2016-09-01
First posted: 2014-12-05
Last updated: 2020-12-14

Locations

1 site across 1 country: Japan

Source: ClinicalTrials.gov record NCT02309671. Inclusion in this directory is not an endorsement.